Biotech & Health Innovation: The 2025 Reset Sets Up Selective Opportunities for 2026
Biotech & Health Innovation was reshaped by a tough financing year in 2025. This sixth year-ender installment examines how that reset is narrowing investor focus as the sector enters 2026.
Read more